Tralokinumab Treatment In Patients With Atopic Dermatitis and Moderate-to-Severe Hand Involvement: Results From the 32-week Phase 3b ADHAND Trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 10, n. 2, p. s744, 2026. DOI: 10.25251/ppt8ep84. Disponível em: https://skin.dermsquared.com/skin/article/view/4105. Acesso em: 29 apr. 2026.